Narrow search
Showing 1 - 10 of 34,139
Cover Image
Financial Risk in the Biotechnology Industry
Golec, Joseph H. - 2007
In the current paper we examine this industry along a number of dimensions and estimate its average financial risk. Specifically, we use Compustat and Center for Research in Securities Prices (CRSP) data from 1982 to 2005 for firms defined by the North American Industry Classification System...
Persistent link: https://www.econbiz.de/10012465042
Cover Image
Pharmaceutical price regulation : public perceptions, economic realities, and empirical evidence
Vernon, John A.; Golec, Joseph - 2008
Persistent link: https://www.econbiz.de/10003779330
Cover Image
An exploratory study of FDA new drug review times, Prescription Drug User Fee Acts, and R&D spending
Vernon, John A.; Golec, Joseph; Lutter, Randall W.; … - In: The quarterly review of economics and finance : journal … 49 (2009) 4, pp. 1260-1274
Persistent link: https://www.econbiz.de/10003903758
Cover Image
Financial risk in the biotechnology industry
Golec, Joseph; Vernon, John A. - 2007
Persistent link: https://www.econbiz.de/10003596151
Cover Image
New estimates of pharmaceutical research and development spending by US-based firms from 1984 to 2003
Golec, Joseph; Vernon, John A. - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 481-482
Persistent link: https://www.econbiz.de/10003543723
Cover Image
European pharmaceutical price regulation, firm profitability, and R&D spending
Golec, Joseph; Vernon, John A. - 2006
Persistent link: https://www.econbiz.de/10003392874
Cover Image
Pharmaceutical R&D spending and threats of price regulation
Golec, Joseph; Hegde, Shantaram P.; Vernon, John A. - In: Journal of financial and quantitative analysis : JFQA 45 (2010) 1, pp. 239-264
Persistent link: https://www.econbiz.de/10003984463
Cover Image
Drug development costs when financial risk is measured using the Fama-French three-factor model
Vernon, John A.; Golec, Joseph; DiMasi, Joseph A. - In: Health economics 19 (2010) 8, pp. 1002-1005
Persistent link: https://www.econbiz.de/10008651842
Cover Image
What's the "interest" in FDA drug advisory committee conflicts of interest?
Golec, Joseph; Vernon, John A. - 2009
Persistent link: https://www.econbiz.de/10003841414
Cover Image
Real option value and path dependence on oncology innovation
Cook, Joseph P.; Golec, Joseph; Vernon, John A.; Pink, … - In: International journal of the economics of business 18 (2011) 2, pp. 225-238
Persistent link: https://www.econbiz.de/10009298454